Results 41 to 50 of about 15,451 (202)

The effect of ovarian stimulation protocol on follicular asynchrony during in vitro fertilization – A retrospective cohort study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To examine the effect of controlled ovarian stimulation (COS) protocol on follicular synchrony in a subsequent in vitro fertilization (IVF) cycle in patients whose previous cycle was canceled due to asynchrony. Methods A single‐center retrospective‐cohort study (January 2018–March 2024), including women undergoing IVF who had: (1) a ...
Alyssa Hochberg, Maria Hincapie, Uri Amikam, Nir Kugelman, William Buckett, Shauna Reinblatt   +5 more
wiley   +1 more source

Evaluation of Clinical Features of Female Patients with Macroprolactinemia

Endocrinology Research and Practice, 2011
Aim: Macroprolactin is a high-molecular-weight form of prolactin. It has been suggested that macroprolactin has no clinical importance because of its decreased or limited bioactivity. Although screening for macroprolactinemia is recommended especially in
Alev Eroğlu Altınova, Müjde Aktürk, Göksun Ayvaz, Sevim Güllü, Metin Arslan, Leyla Mollamahmutoğlu   +5 more
doaj   +2 more sources

Epigenetics in etiopathology of hyperprolactinemia [PDF]

Exploration of Endocrine and Metabolic Diseases
Aim: Epigenetic alterations have been reported in patients with pituitary tumors and those on antipsychotic drugs, which are also responsible for hyperprolactinemia. This suggests a possible role of epigenetics in the etiopathology of hyperprolactinemia.
Amanpreet Kaur Kalsi, Ashutosh Halder, Manish Jain, Jai Bhagwan Sharma   +3 more
doaj   +1 more source

Hyperprolactinemia and Hypopituitarism in Acromegaly and Effect of Pituitary Surgery: Long-Term Follow-up on 529 Patients

Frontiers in Endocrinology, 2022
PurposeStudies on hyperprolactinemia and hypopituitarism in acromegaly are limited. We aimed to analyze the preoperative status, postoperative alterations, and correlated factors of hyperprolactinemia and hypopituitarism in acromegaly patients ...
Xiaopeng Guo, Xiaopeng Guo, Xiaopeng Guo, Xiaopeng Guo, Ruopeng Zhang, Ruopeng Zhang, Ruopeng Zhang, Duoxing Zhang, Duoxing Zhang, Duoxing Zhang, Zihao Wang, Zihao Wang, Zihao Wang, Zihao Wang, Lu Gao, Lu Gao, Lu Gao, Lu Gao, Yong Yao, Yong Yao, Yong Yao, Yong Yao, Kan Deng, Kan Deng, Kan Deng, Kan Deng, Xinjie Bao, Xinjie Bao, Xinjie Bao, Xinjie Bao, Ming Feng, Ming Feng, Ming Feng, Ming Feng, Zhiqin Xu, Zhiqin Xu, Zhiqin Xu, Zhiqin Xu, Yi Yang, Yi Yang, Yi Yang, Yi Yang, Wei Lian, Wei Lian, Wei Lian, Wei Lian, Renzhi Wang, Renzhi Wang, Renzhi Wang, Renzhi Wang, Wenbin Ma, Wenbin Ma, Wenbin Ma, Wenbin Ma, Bing Xing, Bing Xing, Bing Xing, Bing Xing   +57 more
doaj   +1 more source

Developing the Dopamine D3 Receptor (D3R) Antagonist, (R)‐VK4‐116, as a Non‐Opioid Medication for the Treatment of Opioid Use Disorder

Medicinal Research Reviews, EarlyView.
ABSTRACT Opioid use disorder (OUD) remains a major global health challenge, and currently approved treatments (methadone, buprenorphine, and naltrexone) are all opioid receptor‐targeting drugs with limitations in access, adherence, stigma, and use in polysubstance use disorders. Because the dopamine D3 receptor (D3R) is enriched in limbic brain regions
Chia‐Kuei Wu, Yu‐Chih Lin, Junfeng Huang, Bangwei Ding, Pramod Terse, Rahul Nandre, Haksong Jin, Molly Congdon, Kun Shen, Philip Sanderson, Gregory Tawa, Stephanie Mounaud, Marta De Santis, Donald Lo, Elizabeth A. Ottinger, Amy Hauck Newman   +15 more
wiley   +1 more source

Cardiometabolic Treatment Gap in Routine Psychiatric Care: A Cross‐Sectional Study of 1553 Patients

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background People with severe mental illness (SMI) have elevated cardiometabolic morbidity and mortality, with similar concerns increasingly reported in other psychiatric conditions including anxiety disorders and ADHD. Somatic conditions are often underdiagnosed and pharmacologically undermanaged in this population.
Vincent Achour, Melanie Faugere, Laurent Boyer, Christophe Lançon, Theo Korchia   +4 more
wiley   +1 more source

Diagnostic subcategories and hyperprolactinemia.

, 2020
Diagnostic subcategories and hyperprolactinemia.
Sorin Ursoniu (661005), Liana Dehelean (8399481), Ana-Maria Romosan (8399484), Radu-Stefan Romosan (8399493), Victor Dumitrascu (660998), Ion Papava (8399487), Cristina Ana Bredicean (8399490)   +6 more
core   +1 more source

Hyperprolactinemia associated with macroprolactinoma in a 17-year-old: A case report

Case Reports in Women's Health, 2019
Hyperprolactinemia is a relatively common endocrine disorder. In women of reproductive age it may present as the amenorrhea-galactorrhea syndrome, but in milder forms also as menstrual abnormalities or infertility.
Adam Czyzyk, Rafal Kurzawa
doaj   +1 more source

Etiopathogenetic features of hyperprolactinemia in childhood

Zdorovʹe Rebenka, 2021
In recent years, the problem of hyperprolactinemia in children remains relevant because it is one of the most common pathologies of the hypothalamic-pituitary system, causing impaired fertility and reproductive function in adulthood.
O.E. Abaturov, H.O. Nikulina, O.O. Rusakova   +2 more
doaj   +1 more source

Boosting Male Fertility: The Impact of Gonadotropin Therapy on Hypogonadotropic Hypogonadism—A Systematic Review and Meta‐Analysis

Andrology, EarlyView.
ABSTRACT Background Male hypogonadotropic hypogonadism typically presents with azoospermia and is one of the few causes of infertility amenable to a medical intervention. Gonadotropin therapy offers a chance to restore spermatogenesis and fertility in these individuals.
Manou Huijben, Anne Prinsen, Laetitia de Kort, Jetske van Breda   +3 more
wiley   +1 more source